Winter Newsletter – The Authority in RWE

Winter Newsletter – The Authority in RWE

  STATinMED at ASH 2022 64th Annual ASH Meeting & Exposition: Dec 10-13, 2022, New Orleans, LA Presentations Oral Presentation: National view of prevalent and newly-diagnosed patients with multiple myeloma in 2021: A retrospective analysis of national...
Winter Newsletter – The Authority in RWE

Quarterly Newsletter – RWD Insights & Custom Registry

Access robust business intelligence from a reliable team of analysts who understand your goals   Get timely real-world data insights to make business decisions quickly Contact us about RWD Insights Direct STATinMED RWD Custom Registry Actionable, research-ready data...
Robust, Actionable Research-Ready Claims Data

Robust, Actionable Research-Ready Claims Data

              Introducing… Timely resource based on index dates with ability to track time-varying events Patient-centric insights about treatment journey De-identified, tokenized, HIPAA-compliant   Views You Can Use       Collect the variables to...
FAQs: Real-World Questions, Answered.

FAQs: Real-World Questions, Answered.

    Want to learn more about STATinMED and the power of RWD Insights? Here we share some common questions, with answers about our data source and approach. Is your data source HIPAA-compliant? Yes, our data source is de-identified, tokenized, and meets the...
Robust, Actionable Research-Ready Claims Data

2022 Spring Newsletter

It’s been a busy Spring conference season. Read more about our data and presentations below. We have access to more than 80% of the US healthcare system with patient-level data across all-provider types. See how we support evidence generation needs and let us...